Teva Pharmaceutical Industries Ltd 2023 SR
The report outlines Teva's renewed sustainability strategy, Healthy Future, focusing on healthy people, a healthy planet, and a healthy business. In 2023, the company issued its second series of sustainability-linked bonds valued at $2.49 billion, bringing its total to $7.5 billion. Teva achieved its 2025 target of reducing Scope 1 and 2 greenhouse gas emissions by 27% compared to 2019 and committed to reaching net-zero emissions by 2045. Additionally, the company launched seven of its eight committed access to medicines programs and achieved 49% women in management positions.
Company: Teva Pharmaceutical Industries Ltd
Sector: Manufacturing
Country: Israel
Year: 2023
Type: SR
Pages: 102
Back to company
Teva Pharmaceutical Industries Ltd
Healthy Future Report Disclosures
The report outlines Teva's renewed sustainability strategy, Healthy Future, focusing on healthy people, a healthy planet, and a healthy business. In 2023, the company issued its second series of sustainability-linked bonds valued at $2.49 billion, bringing its total to $7.5 billion. Teva achieved its 2025 target of reducing Scope 1 and 2 greenhouse gas emissions by 27% compared to 2019 and committed to reaching net-zero emissions by 2045. Additionally, the company launched seven of its eight committed access to medicines programs and achieved 49% women in management positions.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Published
Apr 30, 2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 3:
Renewable Energy
Water Consumption
Total Waste
Women in Management
Net Zero Target
Employees